Patents by Inventor Hatto Walch

Hatto Walch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
    Patent number: 6951841
    Abstract: Pharmaceutical compositions for oral administration comprising a cyclosporin or macrolide as active ingredient, and a polyethoxylated saturated hydroxy-fatty acid.
    Type: Grant
    Filed: December 15, 2000
    Date of Patent: October 4, 2005
    Assignee: Novartis AG
    Inventors: Klaus Neuer, Monika Petszulat, Hatto Walch
  • Topical application of cetirizine and loratadine
    Patent number: 6790847
    Abstract: The present invention relates to a drug composition containing the non-sedating H1 antihistamines cetirizine, loratadine, mixtures or pharmaceutically acceptable salts thereof for topical application in the form of a gel.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: September 14, 2004
    Assignee: Oramon Arzneimittel GmbH
    Inventor: Hatto Walch
  • Pharmaceutical preparations comprising cyclosporin for oral administration
    Publication number: 20030211983
    Abstract: The invention relates to new cyclosporin-comprising oral pharmaceutical preparations. The new pharmaceutical preparations can be produced more easily and have a good bio-availability. In addition to cyclosporin as active ingredient the preparations contain an alkylene-polyether or alkylene-polyester. Optionally, an alkylene-polyole, an alkylene-glycole, a polyalkylene-glycole, an alkyldiether or partial ether of a lower monooxyalkandiole or polyoxyalkandiole and/or a vegetable oil or its hydrated or hydrolysed product may be contained.
    Type: Application
    Filed: May 1, 2003
    Publication date: November 13, 2003
    Inventors: Monika Petszulat, Klaus Neuer, Hatto Walch
  • Topical application of cetirizine and loratadine
    Publication number: 20030129209
    Abstract: The present invention relates to a drug composition containing the non-sedating H1 antihistamines cetirizine, loratadine, mixtures or pharmaceutically acceptable salts thereof for topical application in the form of a gel.
    Type: Application
    Filed: December 30, 2002
    Publication date: July 10, 2003
    Inventor: Hatto Walch
  • Pharmaceutical preparations comprising cyclosporin for oral administration
    Publication number: 20020107183
    Abstract: The invention relates to new cyclosporin-comprising oral pharmaceutical preparations. The new pharmaceutical preparations can be produced more easily and have a good bio-availability. In addition to cyclosporin as active ingredient the preparations contain an alkylene-polyether or alkylene-polyester. Optionally, an alkylene-polyole, an alkylene-glycole, a polyalkylene-glycole, an alkyldiether or partial ether of a lower monooxyalkandiole or polyoxyalkandiole and/or a vegetable oil or its hydrated or hydrolysed product may be contained.
    Type: Application
    Filed: February 5, 2002
    Publication date: August 8, 2002
    Inventors: Monika Petszulat, Klaus Neuer, Hatto Walch
  • Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid
    Publication number: 20010003589
    Abstract: Pharmaceutical compositions for oral administration comprising a cyclosporin or macrolide as active ingredient, and a polyethoxylated saturated hydroxy-fatty acid.
    Type: Application
    Filed: December 15, 2000
    Publication date: June 14, 2001
    Inventors: Klaus Neuer, Monika Petszulat, Hatto Walch
  • Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators
    Patent number: 6015578
    Abstract: Trapidil is used in the therapy of syndromes that may be influenced by immunomodulators. Trapidil is used for the preparation of a drug for the therapy or prophylaxis of diseases associated with TNF-induced pathological disorders.
    Type: Grant
    Filed: October 9, 1997
    Date of Patent: January 18, 2000
    Assignee: Rodleben Pharma GmbH
    Inventor: Hatto Walch
  • Liquid preparations containing cyclosporin and process for preparing same
    Patent number: 5614491
    Abstract: The present invention pertains to cyclosporin-containing liquid preparations for oral or parenteral administration, as well as to a process for preparing same. Besides the active ingredient cyclosporin, the preparations contain a polyoxyethylene glycerol fatty acid monoester and a monohydric and/or polyhydric alcohol(s). The preparations are stable and well tolerated, and they have higher bioavailability than the preparations known currently.
    Type: Grant
    Filed: November 30, 1994
    Date of Patent: March 25, 1997
    Assignee: Dr. Rentschler Arzneimittel GmbH & Co.
    Inventors: Hatto Walch, Monika Fleck, Klaus Neuer
  • Pharmaceutical composition for the treatment of circulatory disturbances
    Patent number: 4855300
    Abstract: A pharmaceutical combination preparation and method for the treatment of circulatory disturbances comprising a dihydropyridine of the formula ##STR1## in which --R.sub.1, is a CH.sub.3 --O--CH.sub.2 --CH.sub.2 -- or CH.sub.3 group; R.sub.2 is a ##STR2## or CH.sub.3 --CH.sub.2 -- group; R.sub.3 is 4, NO.sub.2 or CL; and R.sub.2 is NO.sub.2, H or CL; and pharmaceutically suitable salts thereof; as active substance A and Pentoxifylline as active substance B, the quantity ratios of A:B being from about 1:150 to about 1:2.
    Type: Grant
    Filed: February 4, 1987
    Date of Patent: August 8, 1989
    Assignee: Dr. Rentschler Arzneimittel GmbH & Co.
    Inventors: Kumaresh Nandi, Helga Fischer, Wilfried Herrmann, Hans Kohne, Wolfgang Lahr, Hein U. Schmersahl, Hatto Walch